PCMT1 as a prognostic marker in breast cancer
The overexpression of the PCMT1 protein in triple negative breast cancer significantly correlated with shorter overall survival. The confirmed association could be a potential prognostic biomarker for patients with TNBC.
Authors
- Patryk Rogaczewski (ORCID: https://orcid.org/0000-0003-0919-5695)
- Łukasz Szylberg (ORCID: https://orcid.org/0000-0003-1349-5906)
- Jędrzej Borowczak (ORCID: https://orcid.org/0000-0001-9873-3285)
- Michał Janiak (ORCID: https://orcid.org/0000-0002-9564-4858)
Institutions
- Nicolaus Copernicus University (PL)
- University of Bydgoszcz (PL)
- Collegium Medicum in Bydgoszcz (PL)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1007/s12094-024-03695-y
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.84